The first two clinical trial participants to receive CRISPR-based treatments for inherited blood disorders have benefited from the experimental therapy and been symptom-free for several months, according to the companies that developed the treatment.
Skipping breakfast affects academic performance
Omega 3 fish oil supplements may benefit some children with ADHD
UTA team aims to improve transportation for older adults in assisted-living communities
Consumption of beans and other legumes benefits cardiovascular health
New curated library unveiled to help address the opioid epidemic
Air pollution associated with memory decline and Alzheimer's-like brain atrophy
What's Driving the Recent Rise in Food Allergies?
Can Cannabis Use Alter Sperm DNA?
Can Antibiotics Increase the Risk of Arthritis?
Easy Home-Based Health Checks You Can Do Today
Using NeuroTrack Assay to Study Neurite Dynamics
Whole Cell Patch Clamp Recordings
Dual-emission Ratiometric Fluorescence Probes
TEM Imaging Modes
Using FMR and TFR-FLIM to Image Matrix Viscosity and Membrane Fluidity
Progress towards a cure for HIV has been the holy grail for HIV researchers since bursting into the public consciousness in 1981.
Painsomnia is experienced by anyone with a chronic pain causing them to lose sleep, which in turn lowers their tolerance to pain.
The vast majority of pollution-related deaths are linked to fine particles less than 2.5 millionths of a metre (known as PM2.5).
Professor Matthias Mann
Matthias Mann explains why applying proteomics-based technologies such as timsTOF could accelerate the diagnosis and prediction of human disease.
News-Medical Life Sciences spoke to Nicholas Dupuis from Biognosys at Neuroscience 2019 about proteomics & DIA mass spectroscopy in neurodegenerative disease research.
News-Medical Life Sciences spoke to Zaber Technologies at Neuroscience 2019 to find out how they are lowering the barriers of automated microscopy.
Building a Successful Email Campaign for a Scientific Audience
Using Webinars to Tell Science Stories – PART II
Reaching Scientists Through Newsletters